MPT64 patch test for the diagnosis of active pulmonary tuberculosis: A randomised controlled trial in Peru

V. Pope, K. A. Sacksteder, J. Coronel Hererra, Robert H Gilman, S. Vargas-Prada, S. Lopez Romero, J. Yafac, E. Sanchez Rios, D. A.J. Moore

Research output: Contribution to journalArticle

Abstract

Setting: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. Objective: To evaluate the sensitivity and specificity of a patch test using MPT64 for the diagnosis of active TB disease. Design: This randomised, double-blind, placebo-controlled, prospective study in Lima, Peru, involved 55 healthy controls and 457 symptomatic individuals referred for routine TB testing by the National TB Control Programme. All subjects underwent a comprehensive diagnostic workup, and received an active patch on one arm and a placebo patch on the opposite arm, which were read after 4 days. Results: Eighty-one (18%) of the symptomatic participants were classified as having definite TB, while an additional 98 (21%) had probable TB. The patch tests performed the same in both groups, with a sensitivity of 27% and specificity of 74%. The area under the receiver operating characteristic curve was 0.495 (95%CI 0.425-0.565). Conclusions: Contrary to existing literature, the MPT64 patch was not sensitive and specific to detect active TB. Given the potential of the test, understanding possible differences in the protein source or underlying genetic factors should be explored further.

Original languageEnglish (US)
Pages (from-to)622-627
Number of pages6
JournalInternational Journal of Tuberculosis and Lung Disease
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Peru
Patch Tests
Pulmonary Tuberculosis
Tuberculosis
Randomized Controlled Trials
Placebos
Sensitivity and Specificity
Mycobacterium tuberculosis
ROC Curve
Proteins
Prospective Studies

Keywords

  • Diagnostic
  • MPT64
  • Patch test
  • TB

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

MPT64 patch test for the diagnosis of active pulmonary tuberculosis : A randomised controlled trial in Peru. / Pope, V.; Sacksteder, K. A.; Hererra, J. Coronel; Gilman, Robert H; Vargas-Prada, S.; Romero, S. Lopez; Yafac, J.; Rios, E. Sanchez; Moore, D. A.J.

In: International Journal of Tuberculosis and Lung Disease, Vol. 22, No. 6, 01.06.2018, p. 622-627.

Research output: Contribution to journalArticle

Pope, V, Sacksteder, KA, Hererra, JC, Gilman, RH, Vargas-Prada, S, Romero, SL, Yafac, J, Rios, ES & Moore, DAJ 2018, 'MPT64 patch test for the diagnosis of active pulmonary tuberculosis: A randomised controlled trial in Peru', International Journal of Tuberculosis and Lung Disease, vol. 22, no. 6, pp. 622-627. https://doi.org/10.5588/ijtld.17.0716
Pope, V. ; Sacksteder, K. A. ; Hererra, J. Coronel ; Gilman, Robert H ; Vargas-Prada, S. ; Romero, S. Lopez ; Yafac, J. ; Rios, E. Sanchez ; Moore, D. A.J. / MPT64 patch test for the diagnosis of active pulmonary tuberculosis : A randomised controlled trial in Peru. In: International Journal of Tuberculosis and Lung Disease. 2018 ; Vol. 22, No. 6. pp. 622-627.
@article{d3dcede6fc92476eb804e3f6f5c46874,
title = "MPT64 patch test for the diagnosis of active pulmonary tuberculosis: A randomised controlled trial in Peru",
abstract = "Setting: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. Objective: To evaluate the sensitivity and specificity of a patch test using MPT64 for the diagnosis of active TB disease. Design: This randomised, double-blind, placebo-controlled, prospective study in Lima, Peru, involved 55 healthy controls and 457 symptomatic individuals referred for routine TB testing by the National TB Control Programme. All subjects underwent a comprehensive diagnostic workup, and received an active patch on one arm and a placebo patch on the opposite arm, which were read after 4 days. Results: Eighty-one (18{\%}) of the symptomatic participants were classified as having definite TB, while an additional 98 (21{\%}) had probable TB. The patch tests performed the same in both groups, with a sensitivity of 27{\%} and specificity of 74{\%}. The area under the receiver operating characteristic curve was 0.495 (95{\%}CI 0.425-0.565). Conclusions: Contrary to existing literature, the MPT64 patch was not sensitive and specific to detect active TB. Given the potential of the test, understanding possible differences in the protein source or underlying genetic factors should be explored further.",
keywords = "Diagnostic, MPT64, Patch test, TB",
author = "V. Pope and Sacksteder, {K. A.} and Hererra, {J. Coronel} and Gilman, {Robert H} and S. Vargas-Prada and Romero, {S. Lopez} and J. Yafac and Rios, {E. Sanchez} and Moore, {D. A.J.}",
year = "2018",
month = "6",
day = "1",
doi = "10.5588/ijtld.17.0716",
language = "English (US)",
volume = "22",
pages = "622--627",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "6",

}

TY - JOUR

T1 - MPT64 patch test for the diagnosis of active pulmonary tuberculosis

T2 - A randomised controlled trial in Peru

AU - Pope, V.

AU - Sacksteder, K. A.

AU - Hererra, J. Coronel

AU - Gilman, Robert H

AU - Vargas-Prada, S.

AU - Romero, S. Lopez

AU - Yafac, J.

AU - Rios, E. Sanchez

AU - Moore, D. A.J.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Setting: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. Objective: To evaluate the sensitivity and specificity of a patch test using MPT64 for the diagnosis of active TB disease. Design: This randomised, double-blind, placebo-controlled, prospective study in Lima, Peru, involved 55 healthy controls and 457 symptomatic individuals referred for routine TB testing by the National TB Control Programme. All subjects underwent a comprehensive diagnostic workup, and received an active patch on one arm and a placebo patch on the opposite arm, which were read after 4 days. Results: Eighty-one (18%) of the symptomatic participants were classified as having definite TB, while an additional 98 (21%) had probable TB. The patch tests performed the same in both groups, with a sensitivity of 27% and specificity of 74%. The area under the receiver operating characteristic curve was 0.495 (95%CI 0.425-0.565). Conclusions: Contrary to existing literature, the MPT64 patch was not sensitive and specific to detect active TB. Given the potential of the test, understanding possible differences in the protein source or underlying genetic factors should be explored further.

AB - Setting: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. Objective: To evaluate the sensitivity and specificity of a patch test using MPT64 for the diagnosis of active TB disease. Design: This randomised, double-blind, placebo-controlled, prospective study in Lima, Peru, involved 55 healthy controls and 457 symptomatic individuals referred for routine TB testing by the National TB Control Programme. All subjects underwent a comprehensive diagnostic workup, and received an active patch on one arm and a placebo patch on the opposite arm, which were read after 4 days. Results: Eighty-one (18%) of the symptomatic participants were classified as having definite TB, while an additional 98 (21%) had probable TB. The patch tests performed the same in both groups, with a sensitivity of 27% and specificity of 74%. The area under the receiver operating characteristic curve was 0.495 (95%CI 0.425-0.565). Conclusions: Contrary to existing literature, the MPT64 patch was not sensitive and specific to detect active TB. Given the potential of the test, understanding possible differences in the protein source or underlying genetic factors should be explored further.

KW - Diagnostic

KW - MPT64

KW - Patch test

KW - TB

UR - http://www.scopus.com/inward/record.url?scp=85046976656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046976656&partnerID=8YFLogxK

U2 - 10.5588/ijtld.17.0716

DO - 10.5588/ijtld.17.0716

M3 - Article

C2 - 29862945

AN - SCOPUS:85046976656

VL - 22

SP - 622

EP - 627

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 6

ER -